32 min listen
Remdesivir and Dexamethasone for the Treatment of COVID-19
Remdesivir and Dexamethasone for the Treatment of COVID-19
ratings:
Length:
36 minutes
Released:
Jul 20, 2020
Format:
Podcast episode
Description
Both remdesivir and dexamethasone have been promoted as effective treatments for COVID-19. JAMA Deputy Editor Greg Curfman, MD, and Professor Rachel Sachs, JD, from the Washington University School of Law discuss the science and health policy aspects of these COVID-19 treatments. Related Article(s): Missed Opportunities on Emergency Remdesivir Use
Released:
Jul 20, 2020
Format:
Podcast episode
Titles in the series (100)
Coronavirus in New York - Report From the Front Lines: The ARDS in COVID-19 patients appears more responsive to PEEP and prone ventilation, but seems to require prolonged ventilation and may be associated with myocardial injury. Michelle N. Gong, MD, MS, Chief of Critical Care Medicine at Montefiore... by Coronavirus (COVID-19) Q&A